These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 6683993

  • 21. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC, Newcom SR, Houghton DC, Baines-Hunter J, Bennett WM.
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [Abstract] [Full Text] [Related]

  • 22. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
    Montine TJ, Borch RF.
    Cancer Res; 1988 Nov 01; 48(21):6017-24. PubMed ID: 2458831
    [Abstract] [Full Text] [Related]

  • 23. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K, Akamatsu K, Matsumoto T, Morikawa K, Honda M, Mitsui H, Koizumi M, Koizumi K, Matsuno T.
    Anticancer Res; 1989 Nov 01; 9(4):987-91. PubMed ID: 2817826
    [Abstract] [Full Text] [Related]

  • 24. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ.
    J Pharmacol Exp Ther; 2001 Jun 01; 297(3):1106-12. PubMed ID: 11356935
    [Abstract] [Full Text] [Related]

  • 25. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M, Viale M, Vannozzi MO, Zicca A, Cadoni A, Merlo F, Gogioso L.
    Toxicol Appl Pharmacol; 1996 Oct 01; 140(2):370-7. PubMed ID: 8887454
    [Abstract] [Full Text] [Related]

  • 26. Drug resistance induction and cross-resistance studies with Pt-complexes.
    Hrubisko M, Balázová E, Ujházy V.
    Neoplasma; 1984 Oct 01; 31(6):649-53. PubMed ID: 6542968
    [Abstract] [Full Text] [Related]

  • 27. [Antitumor activity and toxicity of KB-5424 R, a newly developed antitumor platinum compound].
    Yamaguchi H, Kubota T, Takahara T, Takeuchi T, Furukawa T, Kase S, Josui K, Kodaira S, Ishibiki K, Abe O.
    Gan To Kagaku Ryoho; 1991 Jun 01; 18(7):1135-41. PubMed ID: 2053772
    [Abstract] [Full Text] [Related]

  • 28. Selective reduction of cis-diamminedichloroplatinum(II) nephrotoxicity by ebselen.
    Baldew GS, McVie JG, van der Valk MA, Los G, de Goeij JJ, Vermeulen NP.
    Cancer Res; 1990 Nov 01; 50(21):7031-6. PubMed ID: 2208170
    [Abstract] [Full Text] [Related]

  • 29. Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition.
    Bodenner DL, Dedon PC, Keng PC, Borch RF.
    Cancer Res; 1986 Jun 01; 46(6):2745-50. PubMed ID: 2870800
    [Abstract] [Full Text] [Related]

  • 30. Effect of cis-diamminedichloroplatinum(II) combined with whole body hyperthermia on renal injury.
    Wondergem J, Bulger RE, Strebel FR, Newman RA, Travis EL, Stephens LC, Bull JM.
    Cancer Res; 1988 Jan 15; 48(2):440-6. PubMed ID: 3335012
    [Abstract] [Full Text] [Related]

  • 31. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
    Siddik ZH, Thai G, Yoshida M, Zhang YP, Khokhar AR.
    Anticancer Drug Des; 1994 Dec 15; 9(6):495-509. PubMed ID: 7880375
    [Abstract] [Full Text] [Related]

  • 32. Clinical pharmacology and pharmacokinetics of cis-platinum and analogs.
    Ribaud P, Gouveia J, Bonnay M, Mathe G.
    Cancer Treat Rep; 1981 Dec 15; 65 Suppl 3():97-105. PubMed ID: 7049371
    [Abstract] [Full Text] [Related]

  • 33. Differential toxicity of cis- and trans-diamminedichloroplatinum(II) toward mammalian cells: lack of influence of any difference in the rates of loss of their DNA-bound adducts.
    Roberts JJ, Friedlos F.
    Cancer Res; 1987 Jan 01; 47(1):31-6. PubMed ID: 3791217
    [Abstract] [Full Text] [Related]

  • 34. Antitumor activity and cross-resistance studies with Pt-ascorbato complexes.
    Hrubisko M, Balázová E, Kiss F, Kovácová J, Ujházy V.
    Neoplasma; 1989 Jan 01; 36(6):651-7. PubMed ID: 2615869
    [Abstract] [Full Text] [Related]

  • 35. Monitoring of interaction products of cis-diamminedichloroplatinum(II) and cis-diammine(1,1-cyclobutanedicarboxylato)platinum(II) with DNA in cells from platinum-treated cancer patients.
    Terheggen PM, Dijkman R, Begg AC, Dubbelman R, Floot BG, Hart AA, den Engelse L.
    Cancer Res; 1988 Oct 01; 48(19):5597-603. PubMed ID: 3046743
    [Abstract] [Full Text] [Related]

  • 36. Effect of treatment schedule on antitumor activity of glycolate-0,0'-diammineplatinum(II), a new platinum derivative: comparison with cis-diamminedichloroplatinum(II).
    Suzumura Y, Kato T, Ueda R, Ota K.
    Anticancer Res; 1989 Oct 01; 9(4):1083-8. PubMed ID: 2817790
    [Abstract] [Full Text] [Related]

  • 37. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR, Batzinger RP, Miller EC, Miller JA, Earhart RH.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [Abstract] [Full Text] [Related]

  • 38. [The prospect for cisplatin analogs from the experimental standpoint].
    Tashiro T.
    Gan To Kagaku Ryoho; 1989 Apr 01; 16(4 Pt 2-2):1358-65. PubMed ID: 2543305
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D, Gorneva G, Taxirov S, Spassovska N, Grancharov K.
    Biol Chem; 1999 Nov 01; 380(11):1287-94. PubMed ID: 10614821
    [Abstract] [Full Text] [Related]

  • 40. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.